Fibrate

From Anvita Health Wiki

Jump to: navigation, search

Contents

More Specific Terms

Introduction

  • Also see individual agent.

Indications

Monitor

Mechanism-of-action

Clinical-trials

  • appears to lower the risk for coronary events (benefit modest but may be clinically significant for high risk patients) [3]
  • no benefit in terms of stroke, mortality, or heart failure
  • lack of evidence to support adjunct to statin therapy [4]

More General Terms

Additional Terms

References

  1. Principles of Geriatric Medicine & Gerontology, 4th ed, Hazzard et al (eds), McGraw-Hill, 1999
  2. Anvita Health guideline :id 1539
  3. Jun M et al, Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis The Lancet, Early Online Publication, 11 May 2010 PMID: [1] doi:10.1016/S0140-6736(10)60656-3 [2]
  4. Jackevicius CA et al. Use of fibrates in the United States and Canada. JAMA 2011 Mar 23/30; 305:1217 PMID: [3]
  5. Zhao YY et al New Fibrate Use and Acute Renal Outcomes in Elderly Adults A Population-Based Study Annals of Internal Medicine 2012 156(8):560-569 <PubMed> PMID: [4] <Internet> [5]

Personal tools